论文部分内容阅读
目的探讨研究诊断原发性肝癌的血清甲胎蛋白(AFP)与a-L-岩藻糖苷酶(AFU)组合检测临床应用的必要性。方法回顾性分析我院2007年11月至2009年12月临床确诊的109例原发性肝癌血清AFP与AFU检测数据。结果单一检测AFP阳性率为74.3%,AFU阳性率为87.2%。组合检测综合分析其阳性率可达95.4%。结论组合检测可以明显提高阳性率,为原发性肝癌的临床诊断提供重要依据,说明AFP与AFU组合检测具有必要性。
Objective To investigate the necessity of clinical application of combined detection of serum alpha-fetoprotein (AFP) and a-L-fucosidase (AFU) in the diagnosis of primary liver cancer. Methods A retrospective analysis of our hospital from November 2007 to December 2009 clinically diagnosed 109 cases of primary liver cancer serum AFP and AFU detection data. Results The positive rate of AFP was 74.3% and the positive rate of AFU was 87.2%. Combined detection of the positive rate of up to 95.4%. Conclusion Combined detection can significantly improve the positive rate, providing an important basis for the clinical diagnosis of primary liver cancer, indicating the combination of AFP and AFU detection is necessary.